首页> 外文期刊>HNO >Multimodal laryngeal preservation: Current data-based opinion [Multimodaler Larynxerhalt: Wege zur besseren Patientenselektion]
【24h】

Multimodal laryngeal preservation: Current data-based opinion [Multimodaler Larynxerhalt: Wege zur besseren Patientenselektion]

机译:多模式喉保留:基于数据的最新观点[多模式喉保留:更好地选择患者的方法]

获取原文
获取原文并翻译 | 示例
           

摘要

This article presents the current data and discussion on multimodal laryngeal preservation strategies in advanced laryngeal/hypopharyngeal carcinoma. Principally a distinction is made between simultaneous and induction chemoradiation protocols. In terms of late toxicity and related functional limitations, induction protocols are far superior to simultaneous platinum-based chemoradiation. Currently, the individual response to the first cycle of (short) induction chemotherapy appears to be the most reliable clinical marker for making treatment decisions, and this is under clinical investigation. No standard multimodal therapeutic alternative to laryngectomy exists; therefore, at this time multimodal strategies should only be carried out within the framework of clinical trials.
机译:本文介绍了有关晚期喉/下咽喉癌多模式喉保存策略的当前数据和讨论。原则上,在同步和放射化学辐射方案之间是有区别的。就后期毒性和相关的功能局限性而言,诱导方案远远优于同时进行的铂基化学放射疗法。当前,对(短)诱导化学疗法的第一周期的个体反应似乎是做出治疗决定的最可靠的临床标志,并且这正在临床研究中。没有标准的多式联运的喉切除术替代疗法;因此,此时多模式策略应仅在临床试验的框架内进行。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号